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Genome-wide searches for loci involved in human resistance to malaria are currently being 
conducted on a large scale in Africa using case-control studies.  Here, we explore the utility 
of an alternative approach – “environmental correlation analysis, ECA”, which tests for clines 
in allele frequencies across a gradient of an environmental selection pressure - to identify 
genes that have historically protected against death from malaria.  We collected genotype 
data from 12,425 newborns on 57 candidate malaria resistance loci and 9,756 SNPs 
selected at random from across the genome, and examined their allele frequencies for 
geographic correlations with long-term malaria prevalence data based on 84,042 individuals 
living under different historical selection pressures from malaria in coastal Kenya.   None of 
the 57 candidate SNPs showed significant (P < 0.05) correlations in allele frequency with 
local malaria transmission intensity after adjusting for population structure and multiple 
testing.  By contrast, two of the random SNPs that had highly significant correlations (P < 
0.01) were in genes previously linked to malaria resistance, namely, CDH13, encoding 
cadherin 13, and HS3ST3B1, encoding heparan sulphate 3-O-sulfotransferase 3B1.  Both 
proteins play a role in glycoprotein-mediated cell-cell adhesion which has been widely 
implicated in cerebral malaria, the most life-threatening form of this disease.  Other top 
genes, including CTNND2 which encodes -catenin, a molecular partner to cadherin, were 
significantly enriched in cadherin-mediated pathways affecting inflammation of the brain 
vascular endothelium.   These results demonstrate the utility of ECA in the discovery of 
novel genes and pathways affecting infectious disease.  
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Although many genes affecting susceptibility to malaria have been reported in the literature 
(Kwiatkowski  2005), their validation in large, multi-site, genome-wide phenotype-genotype 
association studies (GWAS) has been disappointing, producing only weak signals (Jallow et 
al. 2009; Timmann et al. 2012; MalariaGEN 2014) or inconsistent results across different 
studies (Atkinson et al. 2007; Cserti and Dzik 2007; Fry et al. 2008a; Clark et al. 2009; 
Mangano et al. 2009; Teo et al. 2010; MalariaGEN 2014). For example, of the 57 SNP loci 
representing 39 ‘candidate’ genes selected for the first phase of the MalariaGen Consortium 
large multi-population case-control studies (MalariaGEN 2008), only five of these loci – the 
sickle cell-causing allele of the beta-haemoglobin gene (HBB), the ‘O’ allele in the ABO gene 
that determines ABO blood group, both of which were well established as malaria protective 
prior to the advent of GWAS studies, G6PD, CD40LG and ATP2B4  – were confirmed 
(MalariaGEN 2014). 
One explanation for the discrepancies between results from large, multi-population 
GWAS and single-site studies may lie in the profound degree of genetic diversity seen over 
very small distances in African populations (Tishkoff and Williams 2002) which, due to 
undetected population structure, coupled with variation in disease transmission, can 
generate both false positive and false negative results (Marchini et al. 2004).  Another 
explanation is the lack of power of marker-based genome scans as a consequence of low 
levels of linkage disequilibrium in African genomes (Conrad et al. 2006; Jallow et al. 2009).  
Improved statistical methods such as genotype imputation, meta-analyses that allow for 
heterogeneous gene effects in different populations, and adjustment for population structure 
using information on thousands of genetic markers can alleviate these problems, though 
only partially (Band et al. 2013).  Further improvements in methodology are required in order 
to find the many polymorphic genes affecting susceptibility to malaria that, apparently, still 
await discovery (Kwiatkowski 2005; Mackinnon et al. 2005).    
An alternative approach to detecting disease-protective alleles using phenotype-
genotype association methods such as case-control studies is to examine population 
patterns of allele frequencies in relation to an environmental variable using ‘environmental 
correlation analysis’ (ECA). Stimulated by the recent advent of genome-wide technologies, 
this ‘landscape genomics’ approach has been successfully pioneered in searches for new 
genes conferring environment-specific adaptation in humans, e.g., to  temperature, altitude 
and diet (Novembre and Di Rienzo 2009; Coop et al. 2010; Hancock et al. 2010; Pritchard et 
al. 2010), and in a diverse range of plant (Eckert et al. 2010; Manel et al. 2010; Hancock et 
al. 2011) and animal species (Foll and Gaggiotti 2008; Nielsen et al. 2009).  The principle 
behind ECA is that when there is differential positive selection pressure on an allele in 
spatially separated populations brought about by geographical variation in environmental 
conditions, and there is also negative selection on the allele due to a fitness cost, the allele 
will, through balancing selection, be maintained at intermediate population frequencies which 
correlate to the strength of selection by the environmental variable.  This ‘fine tuning’ form of 
adaptation through subtle frequency changes in alleles with modest protective effects 
contrasts with the ‘hard sweep’ model of adaptation in which mutations with large beneficial 
effect always approach fixation, even if they carry a moderate fitness cost (Pritchard et al. 
2010). 
Given that human populations in Africa have been exposed to malaria under a range 
of transmission intensities for a very long time, and that many malaria-protective genes are 
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only found at detectable frequencies in populations where malaria occurs and are therefore 
likely to carry a malaria-unrelated fitness cost, we reasoned that adaptation to malaria was 
more likely to follow the fine-tuning model of adaptation than the hard sweep model.  We 
therefore wanted to test whether frequencies of malaria-protective alleles track malaria 
transmission intensity in an African population at equilibrium in its natural disease setting.  
While positive correlations between malaria transmission intensity and frequency of malaria 
resistance alleles have been demonstrated at a global scale for several haemoglobinopathy 
causing genes (Weatherall and Clegg 2001; Piel et al. 2010), an observation that led to 
Haldane’s famous ‘malaria-hypothesis’ (Haldane 1949), there has been much debate on 
whether this principle holds at a local geographic scale (Allison 1954; Foy et al. 1954; Moore 
et al. 1954; Raper 1954; Brass et al. 1955; Siniscalco et al. 1966; Flint et al. 1986; Flint et al. 
1993; Enevold et al. 2007). Counter-arguments are that confounding between the effects of 
migration, origin of the mutation, genetic admixture, non-independence of population 
samples and ecological suitability for malaria have generated spurious geographic 
relationships between malaria transmission intensity and allele frequencies (Flint et al. 
1998).  This problem is general to all geographic-genetic association studies and is not able 
to be overcome through statistics alone (Novembre and Di Rienzo 2009).  However, ECA 
exploits these geographic-genetic correlations and thus, when combined with a recent 
statistical advance (Coop et al. 2010; Gunther and Coop 2013) that takes into account the 
neutral processes that generate allele frequency differences among populations, is well 
suited to disentangling adaptive from spurious clines in allele frequencies across an 
environmental gradient.  
Here, we sought evidence for geographic correlations between malaria exposure and 
allele frequencies of 57 SNPs representing 39 candidate malaria-protective genes, and 
nearly 10,000 random SNP loci representing 3010 protein-coding genes, in a geographically 
small but genetically and environmentally heterogeneous population living on the coast of 
Kenya.  Our aim was to test whether, as for metabolic traits in humans driven by 
environment-related selection pressures (Novembre and Di Rienzo 2009; Coop et al. 2010; 
Hancock et al. 2010; Pritchard et al. 2010), the ECA approach can detect genes that confer 
resistance to infectious diseases.  We further wished to determine whether it could do so on 
a small geographic scale in the genetically and environmentally heterogeneous populations 





Long-term malaria prevalence, based on an average of 3988 records per subpopulation 
collected over a period of 50 years (table 1), differed substantially between subpopulations 
(fig. 1).  These differences were stable through time, with a high average correlation 
between years (0.54), despite very large changes in average malaria prevalence during this 
period (fig. 1D and supplementary fig. S1, Supplementary Material online).  Subpopulation 
differences were also robust to the method of data collection, i.e., from hospital admissions 
vs. from community surveys (fig. 1E).  Assuming that these geographic differences in 
malaria prevalence were also present in previous generations of our study population, these 
results establish the first requirement for the existence of malaria-related clines in 
frequencies of protective alleles, namely, stable, long-term geographical heterogeneity in 
selection pressure by malaria. 












The second requirement for the maintenance of clines – geographic heterogeneity in host 
genetics – was revealed by hierarchical cluster analysis of between-subpopulation 
correlations based on 9,756 random SNPs genotyped in control individuals from two case-
control studies (N = 2,927) (supplementary fig. S2, Supplementary Material online).  Three 
broad genetic clusters were found and these broadly coincided with the three main ethnic 
groups in the study population – Chonyi, Kauma and Giriama - that reside predominantly in 
the south, middle and north of the study area, respectively. Genetic distances between 
subpopulations, estimated by multidimensional scaling based on genotype data as above, 
broadly corresponded to the degree of geographic separation between subpopulations along 
a north-east to south-west transect (fig. 1C).  Malaria generally increased across this 
transect (fig. 1B) thus generating some confounding between genetics, geography and 
malaria transmission. This was partly mitigated by the presence of the genetic outlier 
populations of Jaribuni and Kauma in the centre of the study area where malaria 
transmission intensities were highest (fig. 1) thus providing leverage for distinguishing 
between the null vs. alternative hypotheses under test here, namely, that clines arose as a 
consequence of historical migration and incomplete admixture across the study area vs. 
clines were generated through differential selection pressure by malaria. 
Thus overall, the study population displayed genetic structuring that partially aligned 
to geographic distance.  Subpopulations were not completely genetically isolated, however, 
evident from the generally low correlations in allele frequencies among subpopulations 
(median absolute value of 0.23) and substantial blending of ethnic group composition across 
subpopulations (supplementary fig. S2, Supplementary Material online).  Thus the second 
condition for maintenance of adaptive clines by selection against the eroding effects of gene 
flow - incomplete panmixia - was also met. 
 
Malaria-related Clines in Allele Frequencies of Candidate Malaria Resistance Genes 
Allele frequencies differed significantly between subpopulations for 23 of the 57 candidate 
loci (P < 0.05 by chi-squared test from logistic regression analyses fitting subpopulation as a 
fixed effect).  For 15 of these loci, this variation between subpopulations was significantly 
related to malaria prevalence (P < 0.05 from logistic regression analyses fitting malaria 
prevalence as a linear covariate), i.e., showed environmental correlations. Fig. 2A-C show 
examples of malaria-related frequency clines for the two of the 57 candidate genes that have 
consistently show genome-wide significance in case control studies (Jallow et al. 2009; Band 
et al. 2013; MalariaGEN 2014), namely, HBB and ABO, and for the SNP in the IL22 gene 
that ranked highest for malaria-related clines here. 
However, the above logistic regression analyses above do not allow for the fact that 
populations differ in allele frequencies for reasons unrelated to selection and measurement 
error such as genetic drift, migration and other neutral population genetics processes.  When 
background variation between populations was taken into account by fitting an appropriate 
population genetics model using the Bayenv method (Coop et al. 2010; Gunther and Coop 
2013), none of the 57 candidate loci reached the two-tailed P < 0.05 significance, and only 
one (SNP rs2227478 in the IL22 gene) reached the P < 0.10 level (table S2, Supplementary 
Material online).  This was true whether correlations were computed for all available 
genotype data (N = 10,597, the ‘full data set’), in which case asymptotic significance tests for 
Pearson correlations, which are conservative since they assume zero error of measurement 
in subpopulation frequencies, were applied, or whether correlations were computed from the 
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same number of genotyped individuals as random SNP loci (N = 2,927, the ‘reduced data 
set’), in which case empirical significance tests based on the distribution of correlations 
among random SNPs were used (fig. 3A).  After SNP rs2227478 in the IL22 gene, which had 
environmental correlations of r = 0.59 and r = 0.43  for the full and reduced genotype data 
sets, respectively, with corresponding asymptotic and empirical P-values of 0.08 and 0.06, 
the next highest ranking candidate gene SNPs were rs8176746 that codes for the B allele in 
the ABO locus (r  = 0.48, P = 0.14) and rs2535611 in the ADORA2B gene (r  = -0.35, P = 
0.29) (values based on the full genotype data set; supplementary table S2 and 
supplementary fig. S4A, Supplementary Material online).  
When a test for general population differentiation, i.e., irrespective of malaria, was 
applied using the XTX statistic described by Gunther and Coop (2013), significant (P < 0.05) 
signals were found for SNPs rs1128127 in the DERL3 gene and rs84833095 in the TLR1 
gene, and marginally significant signals (P < 0.10) were found for SNPs rs2706384 in the 
IRF1 gene and rs1803632 in the GBP7 gene (supplementary fig. S4B, Supplementary 
Material online). 
Consistent with the few candidate loci showing individual significance for r and XTX 
was the general lack of significance of global tests of whether the 57 (or top six) candidate 
loci, as a set, showed more extreme correlations than random sets of 57 (or top six) of the 
9,756 random loci (supplementary fig. S4, Supplementary Material online).  For some 
analyses, however, such as when the population was divided into 38 instead of 15 or 11 
subpopulations, global tests indicated that candidate SNPs had, as a set, values of r 
significantly lower in magnitude and values of XTX higher in magnitude than random SNPs 
(supplementary fig. S4, Supplementary Material online). 
 
Environmental Correlations in Random SNP Loci 
Among the top 1% (n = 98) random SNP loci for ECA signals were two genes that have 
previously shown strong genetic associations with malaria (supplementary table S2, 
Supplementary Material online).  The first was in HS3ST3B1 (SNP rs4791574, r = 0.58, P = 
0.007, fig. 2E) which encodes heparan sulphate (glucosamine) 3-O-sulfotransferase 3B1, an 
enzyme that modifies the sulphation patterns of the glycoprotein heparan sulphate.  This 
SNP falls within an intron of HS3ST3B1.  In a previous study in West Africa, 20 SNPs within 
the exons and 3’ and 5’ untranslated regions of this gene and its paralogous neighbouring 
gene HS3ST3A1 were strongly associated with malaria parasitaemia (Atkinson et al. 2012).  
Contrary to expectations from the direction of the environmental correlation, there was a 
strong deficit in frequency of the derived (malaria-favoured) allele relative to the global 
population (0.07 vs. 0.36).  
A second gene among the top 1% random loci that has been previously implicated as 
malaria protective (Band et al. 2013) was CDH13 (rs8048962, r = 0.64, P = 0.0013, fig. 2D) 
which encodes cadherin 13, a member of a large family of proteins that mediate cell-cell 
adhesion as well as extracellular signalling, most known for their role in neural cells but 
which also operate in the vasculature and other tissues.  A further SNP in this gene showed 
a strong environmental correlation with malaria (rs4782731, r = 0.45, P = 0.055).  This result 
confirms the finding from the MalariaGen Consortium’s large multi-population genome-wide 
case-control study for severe malaria in Africa in which CDH13 gene was one of just 18 
genes, excluding the candidate genes, which survived tests of genome-wide significance 
and replicability across populations (Band et al. 2013).  Significant population differentiation 
in other SNPs in this gene has been reported in south-east Asian populations (Liu et al. 
2015b). 
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If it is assumed that there are 20 among the ~20,000 genes in the genome (~0.1%) 
that strongly protect against malaria, given that our random set of 9,756 SNPs included 
3,010  characterised protein-coding genes, it is expected that three of these malaria 
protective genes would be included in our survey.  The probability by chance that exactly 
one of these three would be among the 42 protein-coding genes in the top 1% of SNPs 
(supplementary table S2, Supplementary Material online) is P = 0.04 by hypergeometric test: 
the probability that two or more were among these top 42 is P = 0.0006.  Supporting these 
assumptions is the fact that our survey of random loci included three (ZNF804A, CDH13, 
SIRT3) of 18 novel malaria resistance genes recently uncovered by GWAS (Timmann et al. 
2012; Band et al. 2013; MalariaGEN 2014; MalariaGen 2015) (ATP2B4, MYOT, C10ord57, 
C11orf40, STIM1, MARVELD3 (Timmann et al. 2012), the linked genes ODF3-BET1-RIC8A-
SIRT3 and the linked genes SMARCA5-FREM3-GYPE-GYPB-GYPA, in addition to the three 
above).  
Tests for functional enrichment among the top 10% of SNPs, which represented 382 
protein-coding genes, revealed a significant excess of genes in the cadherin-catenin 
mediated cell-cell adhesion pathway to which CDH13 belongs (P = 0.005, supplementary 
table S3, Supplementary Material online), as well as in the related pathways of G-protein 
coupled signalling that cadherins mediate in response to extra cellular signals from 
cytokines, chemokines, pathogens and mechanical forces, including the rigidifying and 
inflammatory response of the vascular endothelium to shear stress and stretching (Birukov 
2009); the metalloproteases that degrade extracellular matrix proteins, implicated in 
inflammation-related damage to the blood brain barrier (Bruschi and Pinto 2013); and O-
linked glycosylation of proteins in the extracellular matrix that are involved in cell-cell 
adhesion.  These pathways are of particular relevance because of the known role of 
inflammation and damage to permeability of the brain vascular endothelium in cerebral 
malaria (supplementary table S3, Supplementary Material online).  
Individual genes of interest among the top 10% random loci were: CDH5 (r = -.44, P 
= 0.06) which encodes the cadherin most abundantly expressed in the vascular endothelium 
(hence also known as VE-cadherin) which plays a key role in vascular permeability and 
leakage (Gavard 2014); four SNPs within three protocadherin-encoding genes (FAT1, 
PCDH9, PCDH15); two SNPs in genes coding for catenins, the proteins that link cadherins 
to the cell cytoskeleton (CTNND2, P = 0.003, fig. 2F, which codes for -catenin that has 
been shown to mediate inflammation-related pathology of the vascular endothelium in the 
brain (DeBusk et al. 2010), and CTTNNA2, P = 0.05); MAGI2 (P = .009) a homologue of 
MAGI1 which encodes a linker molecule in the cadherin-catenin complex in the vascular 
endothelium (Wallez and Huber 2008) and which a variety of evidence suggests interacts 
with CTNND2 (Schmitt et al. 2014); FN1 (P = 0.002) which encodes the plasma protein 
fibronectin that, like cadherins, binds extracellular matrix proteins, including heparan 
sulphate, and helps promote repair of the vascular endothelium after damage; three genes 
that encode regulators of G-protein signalling that is typically coupled to cadherin activity 
(RGS5, RGS6 (P = 0.01), RGS7), one of which (RGS5) has been shown to be involved in 
endothelial apoptosis (Jin et al. 2009); two genes encoding protein kinases of type C 
(PRKCE, PRKCH) that mediate signal transduction via  G-coupled protein receptors, both 
associated with cerebral ischaemia (Perez-Pinzon et al. 2005; Kubo et al. 2007) and one 
(PRKCE) of which is implicated in protection against the Kenya-endemic Rift Valley Fever 
virus (Filone et al. 2010); ADGRL2 (P = 0.009) that encodes a G-protein coupled receptor 
involved in adhesion and signal transduction in immune regulation (Li et al. 2015) and which 
is closely related to ADGRL1 which is highly expressed in the brain and closely related to 
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one of the malaria resistance candidate genes studied here(EMR1); ANGPT4 which 
encodes a receptor for tyrosine-protein kinases that regulate endothelial cells in the 
vasculature in response to inflammation and structural damage; OPMCL (two SNPs, P = 
0.009 and P = 0.01), encoding a receptor found at high levels in the brain and which 
regulates tyrosine kinases (Wu and Sood 2012); NRP1 (P = 0.005), which codes for 
neuropilin 1, a protein that acts as a receptor for vascular endothelial growth factor (VEGF) 
in association with a tyrosine kinase co-receptor and plays a role in angiogenesis; NRXN3 (P 
= 0.008), a gene encoding a receptor and signalling molecule that is highly expressed in the 
brain; diacylglycerol lipase (DAGLA) that hydrolyses diacylglycerol, an activator of protein 
kinase C; four genes for cytokines or their regulators involved in the immune response to 
microbial infection and inflammatory responses (IRF2, coding for a transcription factor that 
regulates interferon-; IL12RA-AS1, an anti-sense RNA that is expected to control levels of 
interleukin 12, a cytokine that acts on T and natural killer cells and has been genetically 
associated with malaria (Zhang et al. 2010); IL2RA, which encodes a receptor on 
lymphocytes that responds to the key cytokine in defence against microbes, IL2; and IL34 
which encodes a cytokine that is abundant in the spleen, a site of immune defence against 
malaria parasites); a gene encoding a component of the red cell cytoskeleton, ankyrin 3 
(ANK3) and casein kinase 2A1 (CSNK2A1), both which help anchor the Plasmodium 
falciparum protein, PfEMP1, (Hora et al. 2009; Weng et al. 2014) (Hora et al. 2009) to red 
cell membrane where it mediates cytoadhesion to uninfected red cells (Rowe et al. 1995) 
and other host cells (Magowan et al. 1988), including the vascular endothelium (Ockenhouse 
et al. 1992), a process which is thought to lead to cerebral malaria; two genes coding for 
myosin (MYO16, MYO5C); and five genes encoding collagens, one of which (COL4A2) has 
been associated with cerebral small vessel haemorrhage (Rannikmae et al. 2015).   
Of relevance to the second confirmed malaria-associated gene among the top 1% of 
random SNPs (HS3STSB1), is the significant enrichment for the O-linked glycosylation 
pathway among the top 10% of SNPs (supplementary table S3, Supplementary Material 
online).  One gene among the top 1% (POMGNT1, r = 0.62, P = 0.002) and four others in 
the top 10% (GALNT2, GALNT5, GALNT10, GALNT13) code for enzymes that mediate the 
same type of O-linked glycosylation (addition of N-acetyl-galactose amine) that converts the 
H antigen in the ABO blood group system to the A antigen instead of the B antigen which is 
determined by the addition of galactose.  This glycosylation results in higher susceptibility to 
malaria compared with the O blood group for which neither of these glycosylations occur, 
and differential susceptibility of the A vs, B blood group (supplementary table S2, 
Supplementary Material online). 
Other genes of interest in the top 1% that are not obviously related to the enriched 
pathways included those encoding transcriptional regulators (SRPK2 , P<0.00001, and 
RBFOX1 (two SNPs, P = 0.0003 and P = 0.002) that both control alternative splicing, and 
SSBP3 (P = 0.009) which binds DNA); BICD1 (P = 0.006), which regulates Golgi-ER 
transport by recruiting dynein and dynactin; and DNAH14 (P = 0.003), which encodes an 
axonemal dynein.  
 Further details of genes among the top 10% found in enriched pathways and their 
potential relevance to severe malaria are given in supplementary table S3, Supplementary 
Material online. 
Correspondence with Results from a Case-Control Study 
Environmental correlations showed a significant positive relationship with malaria-protective 
effects directly estimated from the malaria case-control study nested within this study 
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population (fig. 3B, P < 0.001 by Spearman rank correlation tests).  Thus in addition to 
detecting novel loci (see above), ECA can be used to validate results from case-control 
studies.   A notable exception to this general correspondence was SNP rs8176746 in the 
ABO gene which codes for the B blood group allele which by ECA is predicted to be 
protective against malaria but in the case-control study analysed here, and in other case-
control studies, when in combination with the A allele in AB heterozygotes, appears to confer 
susceptibility (supplementary table S2, Supplementary Material online).  
Although obtained from the same population, the correspondence between estimates 
of r and the direct estimate of malaria-protective effects from the case-control study cannot 
be attributed to covariance introduced by the estimation procedure. This is because r and 
the malaria-protective effect were estimated independently using genotypes from different 
sets of individuals (on control individuals only in the case of r), as well as by independent 
statistical methods. The correspondence is also unlikely to be attributable to the negative 
correlation between slope and intercept that occurs when there is high sampling error due to 
small sample size, or to extreme allele frequencies, since these were not features of this 
study (supplementary text 1, Supplementary Material online).   
 
Replicability, Power and Bias  
Environmental correlation estimates for candidate loci were generally consistent in ranking 
across different genotype data sets (i.e., those based on control individuals only, malaria 
cases only, or cases and controls combined), and robust to sources of malaria prevalence 
data (hospital data  vs. community surveys in different time periods, supplementary fig. S4A, 
Supplementary Material online).  However, values of r were very sensitive to the number of 
genotyped individuals.  Data simulation showed that both the magnitude and accuracy of 
individual correlation estimates scaled approximately linearly with the number of genotyped 
individuals (N)  below N ~ 20,000 genotypes (i.e., double the size of the experiment reported 
here) and asymptotically beyond that (supplementary text 2, Supplementary Material online).   
This strong dependence of r on N has several important implications for the power and 
implementation of ECA.  First, it requires equal numbers of genotyped individuals for each 
locus in order for correlations to be comparable across loci.  This, in turn, means that 
efficiency of information usage is maximised when genotyping effort is evenly spread across 
loci.  Second, it suggests that increasing N beyond the ~1,000 individuals genotyped per 
subpopulation used in this study is likely to yield considerable gains in power in situations 
where between-subpopulation variation in allele frequencies is low, as was the case here.   
 Including genotype data from case individuals from case-control studies made no 
appreciable difference to correlation estimates (supplementary fig. S4A, Supplementary 
Material online).  Thus the bias in r that is predicted from theory when data derive from 
cases (supplementary text 3, Supplementary Material online) was not evident in our results.      
 
Role of Early-life Mortality in Allele Frequency Clines 
Since malaria-induced mortality occurs mainly during the first two years of life, it is possible 
that the observed correlation between malaria transmission intensity and the frequency of 
the S allele, and other clinal alleles, might have been generated by bias in the sample 
caused by early-life malaria deaths rather than by historical differential selection by malaria 
within the subpopulations. However, the statistical test for an effect on the S allele 
frequency of the age at which children were sampled (mean 7 months, s.d. 2.5) was not 
significant (P > 0.2 from a logistic regression model on individual allele data).  Age effects 
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were also absent (P > 0.2) for the other 56 candidate loci.  The incidence of malaria during 
the period in which children were sampled for genotyping (2006-2010) was at its lowest for 
many years (supplementary fig. S1A, Supplementary Material online) with only two malaria 
deaths out of 6,814 (0.03%) hospital admissions of children under 1 year of age  during the 
birth cohort sampling period vs. 181 deaths out of 28,397 (0.64%) between 1989 and 2002.  
Combined, these results indicate that pre-sampling bias at this or other loci is unlikely to be 




In this study we applied environmental correlation analysis in a human population living 
under different malaria transmission intensities in a small geographic area in coastal Kenya 
in order to search for genes involved in resistance to malaria. We examined 57 candidate 
loci representing 39 genes that have been implicated in malaria pathogenesis: while 15 of 
these showed significant (P < 0.05) malaria-related clines in allele frequency, none of these 
reached significance when compared to a large set of randomly chosen loci and when 
population genetic structure in the background genome was controlled for in the analysis.  
This lack of strong signal by ECA among candidate loci accords well with the findings from 
large multi-site case-control studies for severe malaria in which only a few of the 57 
candidate loci selected by MalariaGen for the first phase of rigorous testing have survived 
genome-wide tests for significance and replicability across populations (Jallow et al. 2009; 
Band et al. 2013; MalariaGEN 2014). Thus our results here, derived using independent 
methodology, help to negatively validate most members of this initial panel of malaria 
resistance candidate genes and thereby reprioritisation of the set of genes taken forward into 
functional studies.   Given that these candidates were selected on the basis of their 
membership of immune regulatory pathways associated with malaria disease severity, which 
are many and complex, or the set of receptors used by the parasite to invade red blood cells 
or bind to host cells, which are also many, their failure to yield strong associations with 
malaria in this and other large studies is perhaps not unexpected.    
By contrast, our tests of nearly 10,000 SNP loci selected at random from across the 
genome revealed multiple loci with highly significant (P < 0.01) environmental correlations 
with malaria.  Two of these (CDH13 and HS3ST3B1) have previously been shown to be 
malaria-associated and both are involved in glycoprotein-mediated cell-adhesion pathways 
that are widely implicated in the pathogenesis of malaria.  Given that there are ~20 malaria -
associated genes that have been confirmed after stringent genome-wide testing and large-
scale replication (Timmann et al. 2012; Band et al. 2013; MalariaGEN 2014; MalariaGen 
2015), of which three were included in our survey of random loci (see Results), it is highly 
improbable that we could have obtained this result by chance alone.  Moreover, seven of the 
40 other genes among the top 1% of loci, are involved in cadherin-mediated adhesion and 
signalling at cell-cell junctions in the brain and/or vascular endothelium (MAGI2, FN1, 
CTNND2, NRP2, NRXN3, RGS6, ADGRL2).  These results are further supported by the 
significant enrichment in closely related pathways among the top 10% of genes.  Our results 
thus provide proof-of-principle that ECA has utility in the detection of novel malaria 
resistance genes through screens of large random sets of loci, and suggest that the 
cadherin-catenin complex operating in the brain or other vascular endothelium may play a 
central role in the pathogenesis of severe malaria.     
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Cadherins form the bridge between cells and are thus key molecules in development 
and tissue repair.  While they are mostly known for their activity in neural cells, they also 
operate in the vasculature, a system that shares many genetic pathways, differentiation 
mechanisms, signalling mechanisms and cross-talk with the nervous system (Carmeliet 
2003).  The cadherins that are abundantly expressed in the vasculature, principally CDH5 
and CDH13, have been shown to mechanically induce cell signalling in the vascular 
endothelium in response to changes in blood flow (Birukov 2009).  When blood vessels 
become obstructed and flow is reduced, increases in shear stress and vessel wall stretch, in 
conjunction with oxidative stress, trigger a signalling cascade that entails activation of 
sodium, chlorine and potassium ion channels, calcium influx, activation of protein C kinases 
and G-protein coupled receptors, induction of NF-B transcription factors, altered expression 
of genes coding for cytoskeletal components, inflammatory responses and cell adhesion, all 
pathways that were found to be enriched in the top 10% of loci here.  The consequences of 
this cascade are rigidification of blood vessels, inflammation and impairment of the 
endothelial barrier function.  CDH13, in particular, has been implicated in this process (Liu et 
al. 2015a). However CDH13, which is found in high abundance in the heart, is unusual in 
that it lacks the cytoplasmic tail that in other cadherins anchors it to internal cytoskeletal 
components such as actin via linker molecules, principally catenins.  This suggests that 
CDH13 mediates alteration of the vascular endothelium through its extracellular signalling, 
rather than binding, activity. A role for cadherin in malaria disease severity fits well with our 
current understanding of the pathogenesis of cerebral malaria in P. falciparum in which it is 
believed that adhesion of parasite-infected cells causes slowing of blood flow and perhaps 
blocking of microcapillaries, leading to higher shear forces, oxidative stress and 
inflammatory responses that damage the vascular endothelium, compromise the blood brain 
barrier and ultimately result in life-threatening disease (Storm and Craig 2014).   
The other previously identified malaria-associated gene found among the top 1% of 
genes here, HSTST3B1, encodes an enzyme that modifies sulphation patterns of heparan 
sulphate (glucosamine), a glycoprotein that is expressed on the surface of various cell types 
in Plasmodium’s human and mosquito hosts (Sinnis et al. 2007).  Sulphate modifications of 
heparan sulphate have been implicated in the migration of sporozoites from skin to liver and 
invasion of liver cells (Frevert et al. 1993; Pradel et al. 2002; Coppi et al. 2007), the invasion 
of merozoites into red blood cells (Xiao et al. 1996; Kobayashi et al. 2010), and the adhesion 
of host cells to the PfEMP1 proteins that are expressed by the parasite on the surface of the 
infected red blood cell (Rowe et al. 1994; Barragan et al. 2000), a process that is associated 
with the most severe form of the disease, cerebral malaria (Carlson et al. 1990; Kaul et al. 
1991; Rowe et al. 1995).  Thus our finding fits well with the known association of heparan 
sulphate in moderating malaria pathogenesis. A recent study in West Africa found strong 
associations between variants in the exons of this gene and malaria parasitaemia measured 
over a two year period (Atkinson et al. 2012).  The exact link between sulphation patterns of 
heparan sulphate, the strength of binding of parasite-infected cells to host cells and 
downstream pathology is not yet well understood. 
 Among the candidate malaria resistance loci tested here, SNP rs2227478 in the IL22 
gene showed the strongest ECA signal.  Although IL22 is generally known as an actor in the 
pro-inflammatory innate immune response to infection, relatively little is known about its role 
in relation to malaria.  Recent evidence from the mouse malaria model P. chabaudi suggests 
that it may protect against liver damage (Mastelic et al. 2012).  Genetic association studies 
that have tested multiple SNPs in this gene have failed to find significant effects on malaria 
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disease severity (Dewasurendra et al. 2012; Apinjoh et al. 2013; Maiga et al. 2013; 
MalariaGEN 2014).  
A malaria-related cline in the S allele from the HBB locus has previously been 
reported in northern Tanzania in a set of 9 villages located at different altitudes in three 
adjacent mountain ranges spanning 350km in which there was evidence of regular genetic 
mixing from genotype data on 15 neutral loci (Enevold et al. 2007).  In our study, we found a 
significant positive cline in S across a malaria transmission intensity gradient but only when 
not allowing for genetic variation between populations in the background genome, as was 
also the case in the study from Tanzania.  Replication of this malaria-related cline in S 
across two independent studies conducted within small geographic regions with subtle 
geographic differences in allele frequency suggests that ‘the malaria hypothesis’ may be 
operating on a fine geographic scale. 
The B-determining allele at the ABO locus showed a positive environmental 
correlation with malaria that was significant (P < 0.05) without adjusting for population 
structure.  This finding contrasts with the results from most case-control studies which have 
shown that, when combined with the A allele (i.e., in AB heterozygotes), this allele renders 
susceptibility to malaria (Fry et al. 2008b; Panda et al. 2011; MalariaGEN 2014).  The 
possible reasons for this discrepancy are discussed below.  
In addition to the genes in the cell-cell adhesion cadherin-catenin, and related 
pathways, two regulators of alternative splicing (RBFOX1 and SRPK2) in neurons and the 
vasculature (Nowak et al. 2010) showed very strong environmental correlations with malaria.  
We suggest that these two genes, in addition to cadherins and catenins that are expressed 
in the vasculature, represent new candidate malaria resistance genes.  
   
Correspondence between ECA and Case-Control Studies 
We found weak but significant correspondence between environmental correlations and the 
direct measures of protection against malaria from a case-control study (fig. 3B).  This 
indicates that ECA can be used to help validate findings from case-control studies, and vice 
versa.  Indeed, a hybrid ECA-case-control approach, as outlined in supplementary text 3 
(Supplementary Material online), could be applied to existing genotype data from case-
control studies in order to capitalise on the already large investment in genome-wide 
searches for malaria-protective genes (MalariaGEN 2008; MalariaGEN 2014).   
It is striking that two SNPs with the strongest protective effects by case-control 
methods stood out as having negative associations with malaria by ECA (fig. 3B).  The most 
striking example of this was the ABO SNP rs8176746 that determines the B vs. A allele 
which showed a positive malaria-related cline with the B-producing allele in this study but in 
most case-control studies (supplementary table S2, Supplementary Material online), 
including that here, is reported to confer slightly higher or equal susceptibility of B carriers 
relative to A carriers, and considerably higher susceptibility of AB heterozygotes compared 
to A or B (Fry et al. 2008b; Panda et al. 2011; MalariaGEN 2014).  The second example was 
the O-determining allele at the ABO locus coded for by SNP rs8176719 which has been very 
consistently demonstrated to protect against severe malaria relative to non-O alleles (A or B) 
in multiple case-control studies (Cserti and Dzik 2007; Fry et al. 2008b; Rowe et al. 2009; 
MalariaGEN 2014) but which showed a negative, albeit non-significant environmental 
correlation with malaria here (r = -0.23, P = 0.35).  
Indeed, despite the fact that the concordance between results from  ECA and case-
control studies based on a large number of loci was significant (P < 0.001) it was, 
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nonetheless, weak.  The first potential explanation for this relates to the design of case-
control studies.  Typically in malaria genetic epidemiology studies, because of the method of 
recruitment of cases, the genetic make-up of cases and controls differs (Band et al. 2013).  
Not only can this readily lead to false associations for loci that confer no protection (Price et 
al. 2010), but it is expected to cause systematic negative bias for protective alleles if, as our 
study illustrates, there are positive geographic associations between the frequency of the 
protective allele and the amount of disease transmission in the local population.  Using the B 
allele at the ABO locus to illustrate, in case-control studies, sampling across the study 
population without rigorous matching for location would generate higher frequencies of the B 
allele malaria among cases than controls because cases are more likely to derive from high 
malaria transmission areas.  This would lead to the interpretation that the B allele confers 
disease susceptibility, in contrast to the implied protective effect by ECA.  We suggest that 
some of the previous inconsistencies in results between different case-control studies might 
be resolved once more attention is paid to the fine-scale population substructure and 
heterogeneity in disease transmission intensity that appears to be typical of malaria case-
control study sites in Africa.  We further suggest that the development of a hybrid statistical 
‘ECA-case-control’ model that accounts for transmission-related clines in allele frequencies 
while simultaneously estimating relative disease risk in cases vs. controls will improve both 
the power and reliability of detection of disease-modifying alleles through the joint use of 
multiple, independent and complementary types of information. 
 Another possibility for low concordance between results from case-control and ECA 
methodology is that resistance-conferring alleles are under balancing selection by malaria on 
the one hand and negative selection by another force.  Indeed, balancing selection is the 
basis for the ‘fine-tuning’ model on which ECA is predicated.  Balancing selection can arise 
within a locus through negative pleiotropy whereby the allele protects against one disease 
but confers susceptibility to another. It can also be mediated by a second locus through 
negative epistasis where alleles at different loci interact to counteract their individual 
protective effects.  The case of the O allele at the ABO locus may be an example of within-
locus balancing selection: whereas the O allele clearly protects against malaria, non-O 
alleles may protect against other diseases caused by viruses and bacteria (Anstee 2010) 
which show strong co-morbidity with malaria (Scott et al. 2011; Church and Maitland 2014).  
If this is true, case-control studies for a single disease in the presence of the other disease 
would lead to under-detection of a protective effect.  In the case of two-locus balancing 
selection (negative epistasis), for which there is a clear example in the malaria-associated 
HBB and HBA loci (Williams et al. 2005; May et al. 2007), signals of protective effects from 
case-control studies for individual loci are likewise expected to be obscured.  Indeed, the 
finding of a strongly discordant result between case-control and ECA studies for a given 
locus may flag the existence of competing selective forces, either from different diseases or 
from interactions with alleles at the same locus or from different loci acting on the same 
disease, thereby potentially stimulating new hypotheses regarding mechanisms of protection 
of these polymorphisms.   
A third source of bias in case-control studies is that selection by malaria in early life 
will enrich the more highly exposed case population with resistance alleles, thus reducing or 
even reversing estimates of protective efficacy.  By contrast, early life protection will 
enhance signals of protection obtained by ECA.  This may well have been the case in the 
study from northern Tanzania by Enevold et al. (1987) in which samples for genotypes were 
collected from children <5y, the age-group in which most malaria mortality occurs.  In our 
study, we could rule out this explanation because of the unusually low incidence of malaria 
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and malaria-related deaths during the recruitment period and because most samples were 
collected at a very early age.  In most malaria case-control studies, however, early-life 
malaria deaths are likely to be substantial prior to the age of collection of samples for 
genotyping.  If ECA were to be retrospectively applied in these populations, results from 
ECA and case-control studies are expected to be less concordant than found here.   
Discrepancies between studies may also arise because the SNPs under analysis are 
not causative, but are instead markers in linkage disequilibrium with the causative mutation 
and thus potentially differ in phase between populations.  Advances in genotype imputation 
and other statistical methods that allow combining of information from multiple SNPs per 
gene and across studies are helping to address this issue (Marchini et al. 2007; Band et al. 
2013) and could be adapted for use in ECA.   
In addition to the biases in ECA and case-control studies discussed above, the fact 
that both designs yield correlative rather than causative results cautions against their over-
interpretation. For example, it could be argued that higher frequencies of the protective 
alleles in high transmission areas are the cause, rather than the consequence, of malaria 
deaths.  However, we feel this is unlikely in this case given that even the most malaria-
protective allele (S) accounts for less than 2% of the variation in malaria incidence in the 
general population (Mackinnon et al. 2010), with ecological factors that drive mosquito 
abundance, rather than genetics, being the primary determinant of disease risk.      
 
Implications 
Our results demonstrate, using malaria as an example and a subset of all genes in the 
genome, that ECA can be used to detect adaptive genes in relatively stable indigenous 
human populations, even with a small geographic area.  They further lend general support to 
the proposal that much of human adaptation to diverse selective environments involves 
subtle shifts in allele frequencies of genes under balancing selection rather than strong 
selective sweeps involving directional, dramatic allele frequency changes (Pritchard et al. 
2010).  If balancing selection is more prevalent than commonly assumed, this would have 
wider implications for understanding the maintenance of quantitative genetic variation (Hill et 
al. 2008).  It would also have practical implications for genome-wide search strategies for 
adaptive genes: if human evolution proceeds mainly through balancing selection, then one 
of the commonly used strategies - scanning the genome for conserved haplotypes as 
signatures of recent hard selection - may detect only a fraction of the targeted genes.  
Likewise, for the reasons discussed above, the widely used case-control methodology for 
genome-wide searches may, in the case of infectious diseases, suffer from bias arising from 
geographic confounding between allele frequencies and disease exposure.  ECA offers a 
number of distinct advantages over traditionally used methods, especially in settings where 
linkage disequilibrium is low and genetic diversity and environmental heterogeneity are high, 
as in Africa.  We propose, therefore, that ECA be incorporated as an additional tool into 
genome-wide case-control studies for disease resistance loci.  It can be easily implemented, 
at no extra cost, whenever the disease-capture methodology, e.g., hospital-based 
surveillance, collects information on the patient’s location of residence.  Results from ECA 
and case control approaches are likely to be complementary, cross-validating and more 
informative with regard to the potential mechanisms by which individual protective alleles 
and their interacting partners affect disease outcomes.     
The possibility that the environmental correlations we observed were driven by 
historical admixture across a geographical malaria gradient cannot be totally dismissed. 
Archaeological and anthropological evidence indicate that the collection of ethnic groups in 
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our study area, known as the Mijikenda, a grouping of nine culturally related though distinct 
groups, have been living in close association with one another since their joint migration 400 
years ago from southern Somalia to their present location where they have been settled 
since (Spear 1974; Spear 1977; Rosa 1987) with, perhaps a migration of their forebears 
from northern Tanzania a millennium before that (Rosa 1987; Spear 2000). There is also 
evidence that this migration of the Mijikenda group along the Somalia-Kenya-Tanzanian 
coastal hinterland has involved several distinct migratory events and settlement of 
subpopulations of the Mijikenda in different locations (Spear 1974; Spear 2000). For 
example, while the Chonyi and Giriama subgroups of the Mijikenda are recorded as 
migrating to the area 400 years ago, this migration did not include the Kauma (Spear 1974), 
thus explaining their distinct genetic makeup as observed here (supplementary fig. S2, 
Supplementary Material online).  Today, the descendants of these sets of migrants still 
maintain their ethnicity, both culturally and genetically, as confirmed here by genotyping, 
and, furthermore, tend to occupy areas of different malaria transmission intensity across the 
north-south transect of our study area.  This has led to geographic patchiness in ethnic 
group overlaid by patchiness in malaria transmission. Such patterns of ethnic grouping by 
ecological type echo a general feature of populations of Kenya and Tanzania as revealed by 
dermatoglyphic studies (Rosa 1985; Rosa 1987), and are likely to be a feature of many other 
populations in Africa.  Thus genetic association studies, whether by case-control or ECA, 
need to ensure that fine-scale population structure is adequately captured in their design and 
analysis. 
 We have proposed that the malaria-related frequency clines observed here are 
caused by balancing selection on genes that are directly selected by survival of malaria.  It is 
also possible, however, that the clines were generated by indirect selection on a genetically 
determined behavioural trait such as propensity to migrate to less disease-ridden areas or to 
alter the environment in a way that reduces exposure to the disease.  For example, the least 
malaria-resistant ethnic group in this study – the Giriama – may have chosen, historically, to 
settle in areas of lower malaria transmission intensity, or to change their farming practices, 
forestation levels or lifestyle in order to limit their malaria exposure.  Humans are 
consummate niche constructors, and much of their adaptation to diverse habitats has been 
attributed to their ability to alter their environment, and hence evolutionary trajectory, through 
cultural as well as genetic inheritance (Laland et al. 2010).  Selection through such indirect 
means will, as for direct selection on survival, leave spatio-genetic signatures in populations 
experiencing different selective environments thus further expanding the prospects of finding 
genes that confer protection against disease using ECA. 
 
 
Materials and Methods 
 
Ethics Statement 
The study was approved by the KEMRI/National Ethics Review Committee. The parents of 




The primary aim of this study was to test for ‘environmental correlations’ between the 
population frequencies of polymorphic alleles in 57 candidate malaria resistance loci and 
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historical levels of malaria transmission intensity in sets of geographically divided 
subpopulations.  To achieve this, environmental correlations were computed between 
estimates of subpopulation allele frequencies obtained from 12,425 children under 1 year of 
age in a genetics birth cohort, and their corresponding subpopulation malaria prevalence 
estimates calculated from 82,042 records on malaria slide positivity from children <15 years 
of age recruited at the hospital or in the community over a 50-year period.  Environmental 
correlations for the 57 candidate loci were compared with those from a control set of 9,756 
putatively neutral SNPs genotyped in a subset of individuals from the birth cohort (table 1).  
Genotypes were also obtained from case individuals from two case-control studies, 
one for severe malaria (MalariaGEN 2014) and one for bacteraemia (Rautanen, A., 
unpublished data).  Environmental correlations were computed using three different 
genotype data sets (control individuals, including bacteraemia cases, malaria cases only, 
and all cases and controls combined); three independent estimates of malaria prevalence 
data (from hospital admissions in 1989-2002, from hospital admissions in 2003-2010, and 
from community surveys in 1960-2007); and three levels of population subdivision (11, 15 
and 38 subpopulations) (table 1). Unless stated otherwise, results on environmental 
correlations presented in the figures are based on malaria prevalence computed from 
combined hospital and community data across all years, genotype data from all control and 
case individuals, and 11 subpopulations.    
   
Study Area 
The study was conducted in an area of coastal Kenya spanning approximately 890km2 
which is served by the Kilifi District Hospital and which is under surveillance by the Kilifi 
Health and Demographic Surveillance System.  This area is divided for administrative 
purposes into ‘locations’ and ‘sublocations’, termed ‘subpopulations’ here (fig. 1A).  A main 
road runs north-south through the area, a major waterway (Kilifi Creek) runs east-west and 
the hospital is located at the intersection of these geographic features near the centre of the 
area. The population comprises  three main ethnic groups – the Chonyi, Giriama and Kauma 
- which constitute a subset of nine loosely defined ethnic groups known as the Mijikenda 
who have occupied the Kenyan coast for the past 400 years after migrating together from 
south Somalia (Spear 1974; Spear 1977). The Kauma typically reside in the centre and west 
of the study area, the Giriama in the north and the Chonyi in the south (fig. 1, supplementary 
fig. S2, Supplementary Material online). 
 
Genotyping 
The primary analysis was conducted on data  from 10,597 children born within the study 
area between August 2006 and September 2010 who form a birth cohort under investigation 
for genetic susceptibility to infectious diseases (the ‘Kilifi birth cohort’) (Williams et al. 2009). 
DNA was extracted from capillary blood samples collected on cohort members at recruitment 
between 3 and 12 months of age.  Children in the birth cohort were genotyped for 57 SNPs 
representing 39 candidate malaria resistance loci (supplementary table S1, Supplementary 
Material online) selected on the basis of their showing malaria protection in previous studies 
or for their known role in red blood cell physiology, receptors for parasite binding or the 
immune response (MalariaGEN 2014).  Genotypes were generated using the Sequenom® 
iPLEX platform for all loci except the HBA that codes for globin for which the -3.7 deletion, 
the most common cause of the African form of +-thalassaemia, was genotyped by PCR 
(Chong et al. 2000). 
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 To form a putatively neutral comparison set, genotypes for 10,000 SNPs chosen at 
random from across the genome, genotype data were generated on 5,214 children from two 
case-control studies, one for severe malaria and one for bacteraemia.  Control individuals for 
these studies were members of the birth cohort described above and so were sampled for 
DNA before 1 year of age whereas case individuals were sampled at the time of disease.  
SNP genotypes for case-control individuals were obtained from the Illumina Omni 2.5M and 
the Affymetrix 6.0 platforms for the malaria and bacteraemia studies, respectively.  The 
10,000 SNPs chosen for analysis were a random subset of those that were included on both 
chips and which were no less than 0.1cM apart in the HapMap combined recombination 
map.  SNPs that fell within the 57 candidate malaria loci, and those that showed allele 
frequency differences of > 0.1 between the two platforms on the overlapping set of samples, 
were excluded, leaving 9,756 SNPs for the final analysis. These represented 3,010 protein-
coding genes and 1,022 non-coding RNA genes: the remainder fell within intergenic regions.  
Ancestral alleles, global allele frequencies and other information on each SNP were 




Indices of long-term malaria transmission intensity were obtained from malaria slide positivity 
data from hospital admissions and from community surveys conducted by the Kenyan 
Ministry of Health.  Hospital data were based on all patients <15y of age who were admitted 
to Kilifi District Hospital between 1989 and 2010.  Because of minor changes to the 
administrative boundaries of locations that took effect in December 2002, these estimates 
were calculated separately for the periods May 1989 to December 2002 (N = 43,037) and 
January 2003 - September 2010 (N = 19,282), a period during which transmission intensity 
was considerably lower (fig. 1D, supplementary fig. S1, Supplementary Material online).  For 
the first period, the data were divided among 11 subpopulations: in 2003, three of the 
administrative areas thus dividing into 15 subpopulations for the second period.  These 15 
were further divided based on administrative boundaries into 38 subpopulations.    
To address the issue of potential bias in subpopulation-specific malaria prevalence 
estimates from hospital admissions data arising from differences in distance to the hospital 
or other factors that affect health-seeking behaviour, a third index of malaria prevalence was 
obtained from 216 independent community-based surveys on 20,331 children conducted 
between 1960 and 2007 in the study area by the Kenyan Ministry of Health and the KEMRI-
Wellcome Trust Research Programme (Snow et al. 2015). Records were categorized into 
the same 11 subpopulations as for the hospital admissions data from 1989-2002, excluding 
subpopulation Gede for which there were no records. 
To obtain best estimates of malaria prevalence by subpopulation, means were 
adjusted for uneven sampling across years and subpopulations by fitting a binomial 
regression model with fixed-level factors of subpopulation, year and source (hospital vs. 
community) as terms in the model.  Predicted means and standard errors for each 
subpopulation, standardised to the median year in the data (2003 for when all hospital and 
community data were combined), were obtained from the fitted model and used in analyses 
for malaria-related clines in allele frequencies described below.  Estimates were obtained for 
each of the three malaria prevalence data sets separately, standardised to 1997 and 2006 
for data on hospital admissions from 1989-2002 and 2003-2010, respectively, and to 1995 
for community survey data from 1960-2007, thus providing three independent environmental 
variables to test for robustness of the ECA results. 











Malaria-Related Clines in Allele Frequencies 
To test for a relationship between malaria transmission intensity and the frequencies of 
malaria resistance alleles across geographically separate subpopulations, we calculated 
subpopulation-specific allele frequencies for all 57 candidate loci using genotype data from 
all children in the birth cohort and then related these to subpopulation-specific malaria 
prevalence in the wider population.  This was done, first, using binomial logistic regression 
analysis and, second, using a Bayesian method to fit a population genetics model of allele 
frequency variation between populations that takes into account both the genetic 
relatedness among populations and error in frequency estimates that arises from small 
samples (see below). 
 The logistic regression model was fitted to binary data on individual alleles obtained 
from genotype data (i.e., two records per child) with subpopulation-specific malaria 
prevalence estimates fitted as a linear covariate.  The reference allele in the analysis was 
the ancestral allele (supplementary table S1, Supplementary Material online): thus the 
results presented here describe the relationship between malaria prevalence and the derived 
allele.  Regression coefficients from the logit scale were back-transformed for the purposes 
of plotting the predicted shape of the malaria-related cline on the original scale. Estimates 
were tested for significance by two-tailed t-test.  A second model was fitted with a single 
fixed-level effect for subpopulation in order to determine whether subpopulations varied 
significantly in allele frequency irrespective of malaria prevalence. A third model was fitted 
with subpopulation as a random effect in order to obtain estimates of the between and within 
subpopulation variances in allele frequency.  These models were fitted using the glmer 
package in R (Bates et al. 2015). The amount of between-population to within-population 
variance in allele frequencies was estimated using the likelihood ratio based pseudo R-
squared statistic implemented in the r.squaredLR command in the MuMIn package in R 
(Bartoń 2015). 
  However, the logistic regression model described above does not take into account 
the genetic relationships between subpopulations that might arise in neutral alleles as a 
result of shared population history and gene flow, and the error measurement in allele 
frequencies, which might bias the correlations between allele frequencies and malaria 
prevalence (Coop et al. 2010).  Therefore we used the ‘Bayenv’ method of Coop et al. 
(2010) in which a null model of multivariate normal population allele frequencies, with 
covariance between populations, is assumed.  This null model is used as the background 
against which a test for a relationship between allele frequencies and an environmental 
variable of interest is made.  By fitting this model in a Bayesian framework, the level of 
statistical support for an environmentally-related cline in allele frequency against the 
distribution of clines under the null model, while simultaneously accounting for genetic 
population structure, is obtained.  In a later version of the Bayenv method (Gunther and 
Coop 2013), statistical tests are performed on ‘standardized’ population allele frequencies in 
order to reduce the effects of outliers. Here, we used the latter method as implemented in 
the ‘Bayenv2.0’ package (Gunther and Coop 2013) to calculate the Pearson correlation, r, 
for each of the 57 candidate loci and the 9,756 random loci.   Empirical P-values for the 57 
candidate loci were computed from the null distribution of r values for the random loci.  Since 
there were considerably fewer genotype data for control loci than candidate loci (table 1), 
thus causing higher sampling variance of allele frequencies and smaller correlations among 
control loci than candidate loci, r for candidate loci was computed from random subsamples 
of the full data set with N  equal to the number of genotypes available for the random SNP 
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loci.  This was repeated 100 times, and the median values of r and its empirical P-value 
were taken to be the best estimates. ‘Asymptotic P-values’ for r were also computed using 
the Student’s t-test method for Pearson correlations with degrees of freedom equal to the 
number of subpopulations minus two. This method assumes that the subpopulation allele 
frequencies are estimated without error and thus provides conservative P-values for r.    
    To allow for multiple testing in the candidate loci, ‘global’ test statistics were 
computed for the 57 candidate loci combined and compared with the distribution of this 
statistic from 1000 random draws of 57 loci from the pool of 9756 random SNP loci plus 57 
candidate loci.  The global statistics used here were, first, the sum of the absolute values of r 
and, second, the sum of the log10 empirical P-values for r.  As above, due to the fewer 
genotypes among random loci than candidate loci, global test statistics for candidate loci 
were based on 100 replicate subsamples of the full genotype data set.  Global test statistics 
were also computed for the six loci showing the strongest correlations out of the set of 57 in 
each draw. 
Comparisons between candidate and random loci were performed using data from all 
9,756 random loci except when some subpopulation frequencies were zero due to small 
sample size, as occurred for loci with low allele frequencies, and when the population was 
divided into 38 subpopulations, in which case the locus was not included in the random SNP 
set.  To check whether differences in the distribution of allele frequencies between candidate 
and random loci affected significance tests, for each candidate locus, a subset of 70-80 
random SNP loci that had allele frequencies within 0.02 of the candidate locus, were 
selected to form a total subset of 4,082 loci which was then used to form the empirical 
distribution for significance testing.  Results using this distribution were compared to those 
when the full set of random SNPs were used for the empirical distribution.   
  
Comparison with Case-Control Results 
To determine whether signals of protection against malaria by ECA corresponded with those 
directly measured by case-control methods, for each SNP, allele count data from all control 
individuals (i.e., the full birth cohort, N = 10,597) and all malaria cases were analysed for 
differences in frequencies between cases and controls by logistic regression under a model 
with a fixed effect for cases vs. controls, a linear covariate for malaria prevalence (using the 
output of standardised values from the Bayenv2 package), and an interaction between 
these.  A reduced model containing only the case-control effect was also fitted.  Estimates of 
the case vs. control effect and estimates of the differences in slope between cases and 
controls (the interaction effect), were regressed on r values from ECA and tested for 
significance based on the Spearman rank correlation.  This non-parametric test was used in 
order to avoid excessive influence of loci with very strong protective effects, such as HBB.   
Since frequencies of protective alleles are biased downwards among cases in case-
control studies relative to overall population frequencies, it may be expected that ECA based 
on data from case-control studies would lead to biased estimates of r.  Conversely, 
environmental correlations might lead to bias in estimates of protective effects in case-
control studies if the environmental correlation is not taken into account in the sampling 
design and analysis.  A theoretical analysis was therefore undertaken to determine the effect 
of case-control status on estimates of r (supplementary text 3, Supplementary Material 
online).  
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To compare genetic distances with geographic distances, multidimensional scaling, 
performed using the cmdscale command in the stats package in  R (R Core Team 2014), 
was applied to the subpopulation genetic variance-covariance matrix (dimension 11 x 11) 
estimated from genotype data on the 9,756 random loci data in the Bayenv package.  This 
yielded a two-dimensional representation of genetic distances among subpopulations.  The 
genetic map was rotated and scaled to obtain the best fit to the geographic map using the 
procrustes function in the vegan package in R (Oksanen et al. 2015).  Genetic clustering of 
subpopulations was visualised by hierarchical clustering using the hclust command within 
the R stats package (R Core Team 2014) and the pheatmap package (Kolde 2015).   
 
Gene Set Enrichment Analyses 
To determine whether the genes with strongest environmental correlations were 
concentrated in specific molecular pathways, the genes represented among the top 10% of 
SNPs by ECA were subjected to over-representation tests using PANTHER (Mi et al. 2013), 
and network based pathway enrichment tests using EnrichNet (Glaab et al. 2012).  
Reference sets used for comparison were all characterised and annotated genes among the 
9,756 random SNPs (i.e., non-coding RNA genes were excluded) and which were found in 
the respective PANTHER and EnrichNet databases.  Tests were made for gene sets based 
on gene ontologies using GO-Slim and KEGG terms, signalling pathway types using 
‘PANTHER Pathways’, and protein domain types using InterPro.  
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FIG. 1.   Geographic, genetic and malaria prevalence maps of the study population.   
(A) Geographic map of study area showing boundaries of the 15 subpopulations. (B) Mean  
and 95% CI (centre and boundary of coloured ellipses) of geographic coordinates of  
residents of all children in the genotyped birth cohort. (C) Genetic map of the subpopulations  
based on multidimensional scaling analysis of data from 9,756 random SNP loci in the  
genotyped controls from the case-control cohort, rescaled to that of the geographic map in  
(B). (D) Malaria prevalence by subpopulation among hospital admissions from 2003-2010 (y- 
axis) vs. that in 1989-2002 (x-axis). Symbols show year-adjusted means: black lines either  
side indicate 95% confidence intervals. (E) Malaria prevalence by subpopulation from  
community surveys from 1960-2007 (y-axis) against hospital malaria prevalence in 1989- 
2002 (x-axis).  Regression analysis of these pre-adjusted means revealed consistent ranking  
in subpopulation malaria prevalence when assessed by community surveys vs. hospital data  
in 1989-2002 (P = 0.08) and in 2003-2010 (P = 0.006), and when measured in two different  
time periods, i.e., hospital data from 1989-2002 vs. 2003-2010 (P = 0.03).  (See  
supplementary fig. S1 in Supplementary Material online for further detail).  Throughout,  
colours of points indicate mean malaria prevalence among hospital admissions in 2003-2010  
according to the legend in (B).  The fewer points in (D) and (E) than in (B) and (C) are due to  
the fact that some subpopulations were split in 2003, as described in the legend to  
supplementary fig. S2 (Supplementary Material online).  
  
FIG. 2.  Malaria-related clines in allele frequencies in three candidate and three  
random loci.  Relationship between malaria prevalence and allele frequency by  
subpopulation of (A) the sickle cell mutation (S allele), (B) the ABO rs8176746 allele that  
codes for the B vs. A phenotype in the ABO blood group system, (C) the derived allele (T) in  
SNP rs2227478 in the IL22 gene locus, (D) the derived allele in SNP rs8048962 in the  
CDH13 gene, (E) the derived allele (C) in SNP rs4791574 in the HS3ST3B1 gene, and (F)  
the derived allele (T) in SNP rs13358276 in the CTTND2. The solid lines show the fit of  
these relationships estimated by binomial logistic regression of individual allele data not  
accounting for population structure.  Colours reflect malaria prevalence as in fig. 1B and size  
of points scale with the square root of the number of genotypes.  Results are based on all  
available genotype data from control individuals for the locus in question and hospital  
malaria prevalence data from 2003-2010 split into 15 subpopulations in order to correspond  
with data in fig. 1.      
FIG. 3.  Environmental correlations for 57 malaria resistance candidate SNPs and  
9,756 random SNPs and their relationship with case-control estimates of malaria- 
protective effects.   (A) The green histogram shows the density distribution of the  
environmental correlation values, r, for 9,756 random SNP loci.  Red circles with black  
outlines indicate values of r for the 57 candidate loci SNPs.  Vertical solid and dashed black  
lines indicate the 5% and 2.5% tails of the distribution for the random SNPs, respectively.  
Values are based on all malaria prevalence data and genotype data from all case and  
control individuals using the same number of observations for candidate and random loci to  
ensure comparability.  (B) Environmental correlations (y-axis) were regressed on odds ratios  
of severe malaria in cases vs. controls (x-axis) obtained by logistic regression analysis of a  
subset of the data used for ECA. Odds ratios reflect the relative probabilities of carrying the  
derived allele in cases vs. controls (x-axis), and thus decrease as the allele’s protective  
effect against malaria increases. Spearman correlations between variables on the x and y  
axes were -0.23 (P = 0.09, 55 d.f.) for candidate gene SNPs, and -0.08 (P < 0.001, 9,406  
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d.f.) for random SNPs. Best-fit linear regression lines are shown with and without two  
candidate locus outliers (SNP rs334 at the HBB locus and SNP rs8176746 at the ABO locus,  
see legend).  Depth of grey shading reflects the local regional density of observations for the  
random SNPs calculated using the smoothScatter function in the R ‘graphics’ package (R  
Core Team 2014).  Closed green symbols indicate the 1% of random SNPs with the most  
extreme values based on their having lowest regional densities.  Closed red symbols  
indicate values for candidate gene SNPs. Candidate SNP outliers for protective efficacy are  
annotated with red text.  Outliers for environmental correlations in random SNPs which are  
discussed in the main text are shown with open green symbols and annotated with green  
text.  Global test statistics on estimates of protective effects indicate that the candidate loci  
had more extreme odds ratios than the random loci (P < 0.001, P = 0.005 excluding rs334 in  
the HBB gene).  The distribution of environmental correlations for candidate loci was similar  
to that for random SNP loci (supplementary fig. S4A, Supplementary Material online).   
  
Table 1.  Data Sets Used for Environmental Correlation Analyses.  
Genotype data  Malaria prevalence data 
Status No. individuals 
 








    




 All  11 82,042 


























a. Number of overlapping individuals, i.e., with genotype data for both random and  
candidate loci, are shown in parentheses.  
b. Genotype data on candidate genes were not available for bacteraemia cases.  
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